The companion app for the InPen digital insulin pen is designed to connect with the company’s latest Simplera continuous glucose monitor, offering users personalized dosing suggestions based on ...
They are calling for the Danish multinational to withdraw its decision to discontinue its provision of human insulin pens “in South Africa and other developing countries”. MSF also wants the ...
You lend them with utmost faith, only to watch them vanish into a black hole. And pens? Pens as a species are the most endangered at work. These days, we hardly use pens to write – most tasks ...
(Bloomberg) -- About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater access to its human insulin and lower prices, while also ...
Novo Nordisk is gradually ceasing the production of its human insulin pens, according to announcements made by the company. As it pivots towards manufacturing its newer obesity and diabetes injections ...
Novo Nordisk, in a strategic shift, is set to phase out the production of human insulin pens globally, although it remains unclear when this will occur. The pharmaceutical giant is redirecting its ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections. The ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections.
No­vo Nordisk said Thurs­day that it plans to even­tu­al­ly halt all of its hu­man in­sulin pen pro­duc­tion glob­al­ly, con­firm­ing an End­points News ...
In a memorandum of demands, they called for a price reduction on analogue insulin pens, which patients are forced to use at an exorbitant price. Novo Nordisk's public affairs director ...
“The product has a patented spring-loaded system that drives insulin through a small opening in a nozzle, virtually pain free.” The device uses high pressure dispersion through the skin.
MSF estimates insulin pens can be produced for $0.94 while being profitable; current U.S. price is $90.69. Diabetes affects 537 million globally, with African cases expected to rise by 134% by 2045.